244 related articles for article (PubMed ID: 16978948)
1. What is the value of axillary dissection or sentinel node biopsy in patients with ductal carcinoma in situ?
Mabry H; Giuliano AE; Silverstein MJ
Am J Surg; 2006 Oct; 192(4):455-7. PubMed ID: 16978948
[TBL] [Abstract][Full Text] [Related]
2. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ.
Dominguez FJ; Golshan M; Black DM; Hughes KS; Gadd MA; Christian R; Lesnikoski BA; Specht M; Michaelson J; Smith BL
Ann Surg Oncol; 2008 Jan; 15(1):268-73. PubMed ID: 17891441
[TBL] [Abstract][Full Text] [Related]
3. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
[TBL] [Abstract][Full Text] [Related]
4. Outcome of patients with ductal carcinoma in situ and sentinel node biopsy.
Meretoja TJ; Heikkilä PS; Salmenkivi K; Leidenius MH
Ann Surg Oncol; 2012 Jul; 19(7):2345-51. PubMed ID: 22395995
[TBL] [Abstract][Full Text] [Related]
5. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
[TBL] [Abstract][Full Text] [Related]
6. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ
Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346
[TBL] [Abstract][Full Text] [Related]
7. Value of sentinel lymph node biopsy in breast ductal carcinoma in situ upstaged to invasive carcinoma.
Sakr R; Antoine M; Barranger E; Dubernard G; Salem C; Daraï E; Uzan S
Breast J; 2008; 14(1):55-60. PubMed ID: 18186866
[TBL] [Abstract][Full Text] [Related]
8. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy.
Mittendorf EA; Arciero CA; Gutchell V; Hooke J; Shriver CD
Curr Surg; 2005; 62(2):253-7. PubMed ID: 15796952
[TBL] [Abstract][Full Text] [Related]
9. [The role of sentinel lymph node biopsy in breast cancer non-invading-duct].
Török K; Péley G; Mátrai Z; Bidlek M; Szabó E; Sinkovics I; Polgár C; Farkas E; Orosz Z; Köves I
Magy Seb; 2006 Jun; 59(3):173-8. PubMed ID: 16937792
[TBL] [Abstract][Full Text] [Related]
10. Is sentinel node biopsy necessary in conservatively treated DCIS?
Julian TB; Land SR; Fourchotte V; Haile SR; Fisher ER; Mamounas EP; Costantino JP; Wolmark N
Ann Surg Oncol; 2007 Aug; 14(8):2202-8. PubMed ID: 17534687
[TBL] [Abstract][Full Text] [Related]
11. Optimal management of ductal carcinoma in situ of the breast.
Sakorafas GH; Farley DR
Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node positivity of patients with ductal carcinoma in situ or microinvasive breast cancer.
Katz A; Gage I; Evans S; Shaffer M; Fleury T; Smith FP; Flax R; Drogula C; Petrucci P; Magnant C
Am J Surg; 2006 Jun; 191(6):761-6. PubMed ID: 16720145
[TBL] [Abstract][Full Text] [Related]
13. The role of sentinel node biopsy in ductal carcinoma in situ of the breast.
Polom K; Murawa D; Wasiewicz J; Nowakowski W; Murawa P
Eur J Surg Oncol; 2009 Jan; 35(1):43-7. PubMed ID: 18723312
[TBL] [Abstract][Full Text] [Related]
14. [Clinical usefulness and perspectives of sentinel node biopsy in the management of breast cancer].
Haid A; Koeberle-Wuehrer R; Offner F; Jasarevic Z; Fritzsche H; Zimmermann G
Chirurg; 2003 Jul; 74(7):657-64. PubMed ID: 12883794
[TBL] [Abstract][Full Text] [Related]
15. Role of sentinel lymph node biopsy in high-risk ductal carcinoma in situ patients.
Moran CJ; Kell MR; Flanagan FL; Kennedy M; Gorey TF; Kerin MJ
Am J Surg; 2007 Aug; 194(2):172-5. PubMed ID: 17618799
[TBL] [Abstract][Full Text] [Related]
16. Axillary recurrence in DCIs: is axillary lymphadenectomy warranted?
Trisal V; Qian D; Wagman LD
Am Surg; 2004 Oct; 70(10):876-80. PubMed ID: 15529841
[TBL] [Abstract][Full Text] [Related]
17. Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.
Caliskan M; Gatti G; Sosnovskikh I; Rotmensz N; Botteri E; Musmeci S; Rosali dos Santos G; Viale G; Luini A
Breast Cancer Res Treat; 2008 Dec; 112(3):513-21. PubMed ID: 18240020
[TBL] [Abstract][Full Text] [Related]
18. Do sentinel node micrometastases predict recurrence risk in ductal carcinoma in situ and ductal carcinoma in situ with microinvasion?
Murphy CD; Jones JL; Javid SH; Michaelson JS; Nolan ME; Lipsitz SR; Specht MC; Lesnikoski BA; Hughes KS; Gadd MA; Smith BL
Am J Surg; 2008 Oct; 196(4):566-8. PubMed ID: 18760400
[TBL] [Abstract][Full Text] [Related]
19. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ
Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
[TBL] [Abstract][Full Text] [Related]
20. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]